University of California, San Diego, ADRC
Welcome,         Profile    Billing    Logout  
 1 Trial 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tuszynski, Mark
NCT05040217: A Clinical Trial of AAV2-BDNF Gene Therapy in Early Alzheimer's Disease and Mild Cognitive Impairment

Recruiting
1
12
US
AAV2-BDNF Gene Therapy, Growth Factor Gene Therapy
Mark Tuszynski, Ohio State University
Alzheimer's Disease, Mild Cognitive Impairment
10/25
10/27

Download Options